Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Discovery and Characterization of Novel Cross-Species BBB-Penetrant Capsids

Brett Hoffman, PhD. Voyager Therapeutics, Cambridge, MA

Disclosures: B. Hoffman: 1; Commercial Interest i.e. Company X; Voyager Therapeutics. 1; What was received? i.e. Honorarium; Salary & Stock. 1; For what role? i.e. Speaker; Employee.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.